NeuroMetrix To Launch Product Targeted at Diabetes Market at the American Diabetes Association 71st Scientific Sessions WALTHAM, Mass., Jun 20, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it expects to meet its planned launch date for its latest product, NC-stat ®
NeuroMetrix Reports Successful Marketing Launch of NC-stat(R)|DPNCheck(TM) at the American Diabetes Association 71st Scientific Sessions WALTHAM, Mass., Jul 06, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it met its planned marketing launch date for NC-stat ®
NeuroMetrix, Inc. Announces Date for 2011 Second Quarter Financial Results Conference Call WALTHAM, Mass., Jul 21, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 second quarter financial results before the opening of the market on July 28, 2011.
NeuroMetrix to Present at Canaccord Genuity Growth Conference WALTHAM, Mass., Aug 02, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N.
NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference WALTHAM, Mass., Sep 07, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N.
NeuroMetrix Reports Compliance With NASDAQ Listing Requirements WALTHAM, Mass., Sep 19, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has received a letter from The NASDAQ Stock Market LLC ("NASDAQ") indicating that it has regained compliance with the minimum bid
NeuroMetrix Names Kenneth J. Snow, M.D. as Chief Medical Officer WALTHAM, Mass., Oct 04, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced the appointment of Kenneth J. Snow, M.D. as Chief Medical Officer. The appointment was effective October 3, 2011.
